Windward Bio

Windward Bio is a clinical-stage biotechnology company working on long-acting antibody therapies for immunological conditions with a lead program in asthma and COPD.

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2026
Stage of Initial Investment
Series B
Initial Investment Year
2026